We present a female Jehovah's Witness patient with concomitant severe left main and left anterior descending coronary artery disease and pheochromocytoma who underwent successful off-pump myocardial revascularization. Perioperative management of this patient included alpha-blockade with Doxazosin followed by beta-blockade with Metoprolol. A short-acting Phentolamine was used for alphablockade before surgery. Because she refused transfusion of blood and blood products, erythropoietin and iron was used to increase her hemoglobin in both the preoperative and postoperative periods. Intraoperative stategy included off-pump myocardial revascularization, the use of a pulmonary catheter to monitor hemodynamics, the use of norepinephrine and epinephrine to increase blood pressure, the employment of the cell saver, and transesophageal echocardiography.
Introduction
Concomitant coronary artery disease and pheochromocytoma are significant surgical challenges. Combined and staged operative procedures have been detailed in the literature w1-9x. We present a case of an off-pump coronary artery bypass procedure performed in a Jehovah's Witness patient with pheochromocytoma. This is the first report in which myocardial revascularization was achieved without blood products and without resection of the pheochromocytoma.
Case report
A 55-year-old Jehovah's Witness female with a past medical history of coronary artery disease, hypertension, noninsulin dependent diabetes, hypercholesterolemia, cerebrovascular disease with transient ischemic attack, and pheochromocytoma, presented to the emergency room with angina. She had a cardiac history significant for 2 myocardial infarctions 2 years previously, leading to stenting of the circumflex coronary artery 3 months previously ago. She had a newly diagnosed right adrenal mass measuring 3 = 2.5 cm. Increased norepinephrine and metanephrine levels in the urine, and elevated plasma levels of norepinephrine, were demonstrated (see Table 1 anterior descending coronary arteries (see Fig. 1 ). Her ejection fraction was 20% with severe mitral valve insufficiency. Echocardiography 3 months previously demonstrated normal left ventricular size and systolic function, an ejection fraction of 55%. Her hemoglobin was 9 gydl. She was a Jehovah's Witness who refused blood and blood products. An intraortic balloon pump (IABP) was placed. The patient was offered off-pump revascularization when her hemoglobin increased. Erythropoietin and ferrous sulfate were started. Her hemoglobin improved to 12 gydl. Preoperative alpha blockade was accomplished with Doxazosin. A shorter acting drug, Phentolamine, was used the day before surgery. Metoprolol was used for beta blockade. She received a Bupivicaine epidural. Erythropoietin (18,000 units per week) was continued prior to surgery and in the postoperative periods. Norepinephrine and epinephrine would be used to increase blood pressure. Pulmonary artery catheter was placed to accurately monitor cardiac hemo- dynamics. Cell saver techniques were employed. With medical management the patient became hemodynamically stable and the IABP was removed to avoid complications during the pre-operative period. Preoperaive echocardiogram demonstrated hypokinesis of the inferior wall and distal anterior wall, ejection fraction of 50%, and mild mitral valve regurgitation.
The patient was premedicated with Midazolam, Fentanyl, and Bupivicaine. She was induced with Etomidate and Vecuronium was used as a muscle relaxant. The anesthetic agent used was Isoflurane. She underwent off-pump myocardial revascularization with saphenous vein grafts to the left anterior descending and obtuse marginal coronary arteries. Internal mammary artery grafting was not chosen in this patient in order to expedite the procedure and to eliminate the internal mammary artery bed as a potential source of bleeding in this patient. Her operation was uncomplicated. She received 2500 cc in crystalloids. Her urine output was 1080 cc. The cell saver contained 200 cc of blood. The cardiac output post operating room was 3.6 lymin and the cardiac index was 1.95 lyminym with an 2 SVO of 71%. Transesophageal echocardiography post sur-2 gery demonstrated an ejection fraction of 45% and no wall motion segment defect.
On postoperative day 1 the patient was awake and alert. Her hemodynamics were a cardiac output of 3.6 lymin, a cardiac index of 1.95 lyminym and a systemic vascular 2 resistance of 1253 dyne * sycm without the use of vasopres-5 sors. Her pulmonary artery catheter was removed and she was transferred to a step-down unit. Her hemoglobin was 9 gydl and she continued on a regimen of erythropoietin 18,000 units subcutaneous injection every other day and 325 mg orally three times a day. The patient was discharged on postoperative day 5 in good condition.
Discussion
Three successful management strategies for the patient with pheochromocytoma and coronary artery disease have been described: (1) Resection of the pheochromocytoma before myocardial revascularization, (2) revascularization before resection of the pheochromocytoma, and (3) combined revascularization and resection of the pheochromocytoma in one procedure. Our patient added to the clinical challenge due to her Jehovah's Witness status and significant comorbidities. It was decided to perform a staged procedure for this patient with myocardial revascularization before laparotomy for resection of the pheochromocytoma. Specific reasons for this decision were: (1) The patient's admitting symptoms were angina, she required an IABP preoperatively, and had an ejection fraction of 20% with severe mitral valve insufficiency. These factors pointed to her cardiac status as requiring initial treatment; (2) The inability to transfuse packed red blood cells or blood products. Bleeding has been a complication of all three management strategies, leading to death of one of the reported cases w3x; (3) The sternotomy and laparotomy would be difficult in a 55-year-old with multiple comorbidities. Reported combined procedures have had longer hospitalizations prior to discharge w4,6x.
Blood conservation and surgical techniques previously outlined by the authors were employed w10x. Off-pump techniques were used to avoid excess catecholamine release seen with cardiopulmonary bypass and hypothermia. We agree with Seah et al., and if cardiopulmonary bypass were necessary, aprotonin therapy to minimize perioperative bleeding is part of our management stategy w4x. The first priority in blood pressure management was blockade of alpha-adrenergic receptors to prevent unopposed vasoconstriction.
